ClinicalTrials.gg
CompletedNCT07096076Updated Aug 5, 2025

The Immediate Effects Of Thoracolumbar Fascia Inhibition And Suboccipital Muscle Inhibition

An interventional study of Thoracolumbar fascia inhibition and Suboccipital inhibition group in Healthy Individuals With Hamstring Tightness, sponsored by Bulent Ecevit University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 25 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-08-05.

Sponsored by Bulent Ecevit University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
75
Allocation
Randomized
Ages
18 Years to 25 Years
Sex
All
01

Study summary

This randomized controlled trial aimed to compare the immediate effects of two self-myofascial release techniques-suboccipital muscle inhibition and thoracolumbal fascia inhibition-on hamstring flexibility, spinal range of motion, and balance in healthy adults. A total of 75 participants with hamstring tightness were randomly assigned to one of three groups: suboccipital inhibition, thoracolumbal inhibition, or control. All participants performed hamstring stretching, and the intervention groups received one of the inhibition techniques immediately after. Outcomes were measured at baseline and within 30 minutes post-intervention. The study found that both techniques led to significant improvements in hamstring flexibility and spinal mobility, with region-specific benefits. The thoracolumbal technique was more effective for trunk and hamstring flexibility, while the suboccipital technique provided greater cervical mobility gains. Balance improvements were limited. These findings support the use of targeted myofascial interventions in clinical practice.

02

Conditions studied

  • Healthy Individuals With Hamstring Tightness
03

In context

Lead sponsor

Bulent Ecevit University is the lead sponsor of 47 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 25 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthy volunteers between the ages of 18 and 25
  • Hamstring muscle tightness as defined by Active Knee Extension Test (AKET) ≥ 20°
  • Ability to follow study instructions and provide
  • No participation in other clinical studies within the last 3 months

Exclusion criteria

Exclusion Criteria:

  • AKET \< 20° (i.e., no hamstring tightness)
  • History of musculoskeletal, neurological, or systemic diseases affecting balance or flexibility
  • Recent injury or surgery involving the spine, pelvis, or lower extremities
  • Use of medications affecting muscle tone or balance
  • Inability to perform the required movements or assessments
  • Pregnancy or suspected pregnancy
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
75 participants (actual)

Study arms

  • Active comparator
    Control Group

    Other: hamstring stretching

  • Experimental
    Thoracolumbar fascia inhibition group

    Other: Thoracolumbar fascia inhibition · Other: hamstring stretching

  • Experimental
    Suboccipital inhibition group

    Other: Suboccipital inhibition group · Other: hamstring stretching

Interventions

  • OtherThoracolumbar fascia inhibition

    Soft tissue mobilization: Participants will be asked to lie on their backs without a pillow in a hook-lying position, placing a foam roller under the inferior part of the scapula and clasping their hands behind the cervical region. Then, they will be instructed to lift their hips off the ground and roll the foam roller in a cranial and caudal direction from the inferior scapular region to the sacral area for 30 seconds, performing flexion and extension movements with their knees. This application will be performed in a total of 4 sets.

  • OtherSuboccipital inhibition group

    Soft tissue mobilization: Participants will be asked to lie in a supine position on an appropriate surface and keep their knees in extension. Then, they will be instructed to hold both ends of a sheet and place the middle part of the sheet on the plantar surface of one foot. Using the sheet and by dorsiflexing the ankle, they will pull the extended leg toward themselves. This position should be maintained for 30 seconds (8). It is important that the opposite knee does not flex during the exercise. The application will be performed bilaterally.

  • Otherhamstring stretching

    Participants performed passive hamstring stretching using a sheet for self-assistance. Participants will be asked to lie supine on an appropriate surface and keep their knees in extension. Then, they will be instructed to hold both ends of a sheet and place the middle part of the sheet on the plantar surface of one foot. Using the sheet and performing ankle dorsiflexion, they will pull the leg-kept in knee extension-toward themselves. This position should be held for 30 seconds (8). It is important that the opposite knee does not move into flexion during the exercise. The application will be performed bilaterally.

06

What researchers measure

Primary outcomes

  1. Change in Cervical Range of Motion (degrees) from Baseline to Post-Intervention

    Cervical range of motion (flexion, extension, lateral flexion, rotation) in healthy individuals with hamstring tightness.

    Time frame: Baseline and immediately (within 30 minutes) post-intervention

  2. Change in Finger-to-Floor Distance from Baseline to Post-Intervention

    Finger-to-Floor Distance was used to assess hamstring flexibility. Measurements were taken pre-intervention and within 30 minutes following the intervention.

    Time frame: Baseline and immediately (within 30 minutes) post-intervention

  3. Change in Y Balance Test from Baseline to Post-Intervention

    The Y Balance Test was used to assess dynamic balance, with participants reaching in the anterior, posteromedial, and posterolateral directions while standing on one leg. The average reach distance in centimeters (cm) was recorded for each direction. The test was administered at baseline and within 30 minutes post-intervention to assess immediate changes in balance performance.

    Time frame: Baseline and immediately (within 30 minutes) post-intervention

  4. Change in Active Knee Extension Angle (degrees) from Baseline to Post-Intervention

    Active Knee Extension Test (AKET): Degree of knee extension measured using a goniometer. Higher values indicate greater flexibility.

    Time frame: Baseline and immediately (within 30 minutes) post-intervention

  5. Change in The Stork Balance Test from Baseline to Post-Intervention

    The Stork Balance Test was used to evaluate static balance by measuring how long (in seconds) a participant could maintain a balanced stance on one leg.

    Time frame: Baseline and immediately (within 30 minutes) post-intervention

  6. Change in Lumbal Range of Motion (degrees) from Baseline to Post-Intervention

    Lumbal range of motion (flexion, extension) in healthy individuals with hamstring tightness.

    Time frame: Baseline and immediately (within 30 minutes) post-intervention

07

Study locations

1 site
  • Zonguldak Bülent Ecevit Üniversity
    Kozlu, Zonguldak Province 67600, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: Yes — All procedures involving human participants were conducted in accordance with ethical standards. Written informed consent was obtained from all participants prior to the study. Data other than the participants' personal information (e.g., pre- and post-intervention muscle flexibility measurements) were used solely for research purposes. Participant privacy and confidentiality were strictly protected throughout the study.

Supporting information: Study protocol, Statistical analysis plan

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Mar 2025 to primary completion in Jun 2025, 2 months.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 25, 2025
First posted
Jul 31, 2025
StartActual
Mar 28, 2025
Primary completionActual
Jun 2, 2025
CompletionActual
Jun 26, 2025
Last update
Aug 5, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 5, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07096076
Lead sponsor
Bulent Ecevit University
Responsible party
Sanem ŞENER (Assistant Professor, Bulent Ecevit University) — Principal investigator
First posted
Jul 31, 2025
Start date
Mar 28, 2025
Primary completion
Jun 2, 2025
Completion
Jun 26, 2025
Last update
Aug 5, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion